Dr. Scott C. Ritchie
@sritchie73.bsky.social
British Heart Foundation Cambridge Centre for Research Excellence Fellow & Assistant Professor of Research in the Department of Public Health and Primary Care at the University of Cambridge
https://scholar.google.com/citations?user=K8qTnLUAAA
https://scholar.google.com/citations?user=K8qTnLUAAA
At #EASD and interested in learning about how polygenic risk scores can be use to improve prediction and prevention of type 2 diabetes? Come see my talk at 17:25 today in the Milan Hall as part of the EASD-ADA Joint Symposium. I'll also be around until Friday afternoon if anyone wants to chat.
September 16, 2025 at 12:44 PM
At #EASD and interested in learning about how polygenic risk scores can be use to improve prediction and prevention of type 2 diabetes? Come see my talk at 17:25 today in the Milan Hall as part of the EASD-ADA Joint Symposium. I'll also be around until Friday afternoon if anyone wants to chat.
Reminds me of this classic tweet:
August 7, 2025 at 10:14 PM
Reminds me of this classic tweet:
Now's a good time for a reminder about the internet wayback machine: web.archive.org
February 6, 2025 at 4:40 PM
Now's a good time for a reminder about the internet wayback machine: web.archive.org
Modelling the impact of these in the wider UK population, we show that supplementing screening with conventional risk factors (i.e. SCORE2) with targeted follow-up with NMR scores and PRSs could increase the # of CVD events prevented from 201 to 370 per 100K screened
Thread 3/3
Thread 3/3
November 20, 2024 at 5:46 PM
Modelling the impact of these in the wider UK population, we show that supplementing screening with conventional risk factors (i.e. SCORE2) with targeted follow-up with NMR scores and PRSs could increase the # of CVD events prevented from 201 to 370 per 100K screened
Thread 3/3
Thread 3/3
Using the latest UK Biobank data, we show that:
- Integrating NMR scores and PRSs with SCORE2 can moderately improve 10-year CVD risk prediction (by up to 9%)
- Risk stratification is also improved when using ESC 2021 guideline-recommended risk categorisation
Thread 2/3
- Integrating NMR scores and PRSs with SCORE2 can moderately improve 10-year CVD risk prediction (by up to 9%)
- Risk stratification is also improved when using ESC 2021 guideline-recommended risk categorisation
Thread 2/3
November 20, 2024 at 5:46 PM
Using the latest UK Biobank data, we show that:
- Integrating NMR scores and PRSs with SCORE2 can moderately improve 10-year CVD risk prediction (by up to 9%)
- Risk stratification is also improved when using ESC 2021 guideline-recommended risk categorisation
Thread 2/3
- Integrating NMR scores and PRSs with SCORE2 can moderately improve 10-year CVD risk prediction (by up to 9%)
- Risk stratification is also improved when using ESC 2021 guideline-recommended risk categorisation
Thread 2/3